About FDA
SMG 1114.71
FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS
FOOD AND DRUG ADMINISTRATION
OFFICE OF THE COMMISSIONER
OFFICE OF THE CHIEF SCIENTIST
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH
OFFICE OF THE CENTER DIRECTOR
OFFICE OF RESEARCH
DIVISION OF NEUROTOXICOLOGY
Effective Date: 01/13/2009
1. DIVISION OF NEUROTOXICOLOGY (DAECCF).
A. Develops and validates quantitative biomarkers of neurotoxicity and utilizes these biomarkers to clarify mechanisms of neurotoxicity.
B. Develops a multidisciplinary approach that integrates neurohistological, neurochemical, neurophysiological, and behavioral assessments to determine effects and mechanisms in neurotoxicology.
C. Determines target tissue concentrations and cellular interactions of neurotoxicants.
D. Reduces the uncertainty of extrapolation of neurotoxicity across species by using rodent and nonhuman primate animal models and comparing the results to humans when possible.
E. Administers and has lead scientific responsibilities for NCTR’s Neurotoxicology Program.
2. AUTHORITY AND EFFECTIVE DATE.
The functional statements for this Office were approved by the Deputy Commissioner, Food and Drug Administration effective January 13, 2009.
| STATUS (I, R, C) | DATE APPROVED | LOCATION OF CHANGE HISTORY | CONTACT | APPROVING OFFICIAL |
|---|---|---|---|---|
| Initial | 07/29/2008 | N/a | OC/OO/OM/OMP | Associate Director, Office of Executive Programs and Services, NCTR |
| Revision | 01/13/2009 | N/a | OC/OO/OM/OMP | Commissioner of the Food and Drug Administration |

